Adamas Pharmaceuticals Inc
ADMSDelisted Nov 24, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001328143
Adamas Pharmaceuticals Inc was delisted on Nov 24, 2021; its insiders filed their last Form 4 on Nov 24, 2021; 63 institutions reported holding it in 13F filings for Q3 2021, worth $147.6M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Adamas Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 67 | 63 | −4 |
| Shares | 30.3M | 30.0M | −302.9K (−1.0%) |
| Value | $160.3M | $147.6M | −$12.6M (−7.9%) |
New holders (7)
Institutions that held Adamas Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 38,545 | $189.0K | 0.00% |
| Campbell & CO Investment Adviser LLC | 29,500 | $145.0K | 0.05% |
| Group One Trading, L.P. | 16,483 | $81.0K | 0.00% |
| Algert Global LLC | 15,936 | $78.0K | 0.01% |
| Two Sigma Securities, LLC | 11,915 | $59.0K | 0.01% |
| United Bank | 11,200 | $55.0K | 0.01% |
| Capstone Investment Advisors, LLC | 10,123 | $50.0K | 0.00% |
Sold out (11)
Institutions that held Adamas Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 105,551 | $557.0K |
| Fisher Asset Management, LLC | 59,771 | $316.0K |
| Susquehanna Fundamental Investments, LLC | 40,590 | $214.0K |
| Leonteq Securities AG | 30,000 | $158.4K |
| Jump Financial, LLC | 23,191 | $122.0K |
| Engineers Gate Manager LP | 18,434 | $97.0K |
| Squarepoint Ops LLC | 17,561 | $93.0K |
| XTX Topco Ltd | 16,357 | $86.0K |
| Deutsche Bank AG | 13,620 | $72.0K |
| Deltec Asset Management LLC | 10,000 | $53.0K |
| Tower Research Capital LLC (TRC) | 7,520 | $40.0K |